Eluxadoline 5S and 4S5R) Methods for predicting cancer treatment

Methods for predicting cancer treatment responsiveness to phosphatidylinositol 3-kinase (PI3K) inhibitors

CAS Number: 1009298-59-2

NPS 2143 administration (1 mg/kg) by i

Smiles: OC1=CC=CC=C1/C=C/C(=O)/C=C/C1=CC=CC=C1O

24 hours) blocks Cul3 neddylation at 3 μM and also has certain inhibition of Cul1 neddylation at 10 μM but was not effective in inhibiting neddylation of other cullin members

Eluxadoline 5S and 4S5R) Methods for predicting cancer treatmentEluxadoline is an orally active drug approved for the treatment of diarrhea and abdominal pain in individuals with diarrhea predominant irritable bowel syndrome (IBS D). Eluxadoline is a and opioid receptor agonist and opioid receptor antagonist that acts locally in the enteric nervous system, possibly decreasing adverse effects on the central nervous system. This product is discontinued (DEA Schedule IV). Product information CAS Number: 864821 90 9